Taysha Gene Therapies (TSHA) had the highest return between July 27, 2023 and August 31, 2023 by a small-cap US stock, returning 407.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Taysha Gene Therapies (TSHA) | 7/27/2023 - 8/31/2023 | 407.94% |
Akso Health Group ADR (AHG) | 7/27/2023 - 8/31/2023 | 240.74% |
Neuropace (NPCE) | 7/27/2023 - 8/31/2023 | 133.58% |
UroGen Pharma (URGN) | 7/27/2023 - 8/31/2023 | 87.55% |
Lifeway Foods (LWAY) | 7/27/2023 - 8/31/2023 | 77.69% |
M-tron Industries (MPTI) | 7/27/2023 - 8/31/2023 | 66.67% |
Silence Therapeutics (SLN) | 7/27/2023 - 8/31/2023 | 61.82% |
Palvella Therapeutics (PVLA) | 7/27/2023 - 8/31/2023 | 61.43% |
Eton Pharmaceuticals (ETON) | 7/27/2023 - 8/31/2023 | 58.45% |
Groupon (GRPN) | 7/27/2023 - 8/31/2023 | 56.78% |
Gyre Therapeutics (GYRE) | 7/27/2023 - 8/31/2023 | 55.56% |
Orion (ORN) | 7/27/2023 - 8/31/2023 | 51.42% |
American Coastal Insurance (ACIC) | 7/27/2023 - 8/31/2023 | 50.2% |
Nexa Resources (NEXA) | 7/27/2023 - 8/31/2023 | 48.84% |
Fulcrum Therapeutics (FULC) | 7/27/2023 - 8/31/2023 | 47.86% |
Lifezone Metals (LZM) | 7/27/2023 - 8/31/2023 | 47.57% |
Tilray (TLRY) | 7/27/2023 - 8/31/2023 | 46.53% |
Capricor Therapeutics (CAPR) | 7/27/2023 - 8/31/2023 | 46.28% |
Brainsway (BWAY) | 7/27/2023 - 8/31/2023 | 45.57% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 7/27/2023 - 8/31/2023 | 45.47% |
Upwork (UPWK) | 7/27/2023 - 8/31/2023 | 42.82% |
Armata Pharmaceuticals (ARMP) | 7/27/2023 - 8/31/2023 | 39.52% |
Seneca Foods Corp B (SENEB) | 7/27/2023 - 8/31/2023 | 39.34% |
Limbach (LMB) | 7/27/2023 - 8/31/2023 | 39.07% |
Up Fintech (TIGR) | 7/27/2023 - 8/31/2023 | 37.92% |
Small-cap stocks are treated as having a market cap between $300M and $2B.